GFM
GILD icon

GF Fund Management’s Gilead Sciences GILD Stock Holding History

GF Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.9M Sell
300,113
-7,939
-3% -$1.05M 0.45% 41
2026
Q1 		$42.9M Sell
308,052
-5,026
-2% -$704K 0.72% 31
2025
Q4 		$38.4M Buy
313,078
+14,531
+5% +$1.77M 0.66% 33
2025
Q3 		$33.1M Sell
298,547
-1,455
-0.5% -$165K 0.6% 39
2025
Q2 		$33.3M Buy
300,002
+7,162
+2% +$762K 0.67% 31
2025
Q1 		$32.8M Buy
292,840
+8,484
+3% +$875K 0.77% 29
2024
Q4 		$26.3M Buy
+284,356
New +$25.6M 0.57% 35

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GF Fund Management's GILD Position: Q2 2026 in Review

GF Fund Management reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $1.05M and leaving 300,113 shares worth $37.9M. The position accounts for 0.45% of the portfolio, ranked #41.

GF Fund Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $42.9M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • GF Fund Management held 300,113 shares of Gilead Sciences worth $37.9M as of Q2 2026.
  • GF Fund Management sold 7,939 Gilead Sciences shares in Q2 2026, an estimated $1.05M.
  • Gilead Sciences made up 0.45% of GF Fund Management's portfolio in Q2 2026, its #41 holding.
  • GF Fund Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Gilead Sciences position peaked at $42.9M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.